Resultados de búsqueda - Justin Cidado
- Mostrando 1 - 15 Resultados de 15
-
1
Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy por Justin Cidado, Ben Ho Park
Publicado 2012Revisão -
2
Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and re-sensitizes acute myeloid leukemia to BCL-2 inhibition por Bing Z. Carter, Po Yee Mak, Wenjing Tao, Marc O. Warmoes, Philip L. Lorenzi, Duncan H. Mak, Vivian Ruvolo, Lin Tan, Justin Cidado, Lisa Drew, Michael Andreeff
Publicado 2020Artigo -
3
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma por Taylor Hashiguchi, Nur Bruss, Scott Best, Vi Lam, Olga V. Danilova, Cody Paiva, Joelle Wolf, Erin W. Gilbert, Craig Okada, Prabhjot Kaur, Lisa Drew, Justin Cidado, Peter J. Hurlin, Alexey V. Danilov
Publicado 2019Artigo -
4
Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies por Joan Montero, Cécile Gstalder, Daniel J. Kim, Dorota Sadowicz, Wayne Miles, Michael P. Manos, Justin Cidado, J. Paul Secrist, Adriana E. Tron, Keith T. Flaherty, F. Stephen Hodi, Charles H. Yoon, Anthony Letai, David E. Fisher, Rizwan Haq
Publicado 2019Artigo -
5
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas por Raphael Koch, Amanda L. Christie, Jennifer L. Crombie, Adam C. Palmer, Deborah Plana, Kay Shigemori, Sara Morrow, Alexandria Van Scoyk, Wenchao Wu, Elizabeth Brém, J. Paul Secrist, Lisa Drew, Alwin G. Schuller, Justin Cidado, Anthony Letai, David M. Weinstock
Publicado 2018Artigo -
6
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells por Justin Cidado, Scott Boiko, Theresa A. Proia, Douglas Ferguson, Steven W. Criscione, Maryann San Martin, Petar Pop-Damkov, Nancy Su, Valar Nila Roamio Franklin, Chandra Sekhar Reddy Chilamakuri, Clive S. D’Santos, Wenlin Shao, Jamal Saeh, Raphael Koch, David M. Weinstock, Michael Zinda, Stephen E. Fawell, Lisa Drew
Publicado 2019Carta -
7
<i>MACROD2</i> overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers por Morassa Mohseni, Justin Cidado, Sarah Croessmann, Karen Cravero, Ashley Cimino‐Mathews, Hong Yuen Wong, Rob Scharpf, Daniel J. Zabransky, Abde M. Abukhdeir, Joseph P. Garay, Grace M. Wang, Julia A. Beaver, Rory L. Cochran, Brian Blair, Dina Rosen, Bracha Erlanger, Pedram Argani, Paula J. Hurley, Josh Lauring, Ben Ho Park
Publicado 2014Artigo -
8
<i>HER2</i> missense mutations have distinct effects on oncogenic signaling and migration por Daniel J. Zabransky, Christopher L. Yankaskas, Rory L. Cochran, Hong Yuen Wong, Sarah Croessmann, David Chu, Shyam M. Kavuri, Monica Red Brewer, Dina Rosen, W. Brian Dalton, Ashley Cimino‐Mathews, Karen Cravero, Berry Button, Kelly Kyker-Snowman, Justin Cidado, Bracha Erlanger, Heather A. Parsons, Kristen M. Manto, Ron Bose, Josh Lauring, Carlos L. Arteaga, Κωνσταντίνος Κωνσταντόπουλος, Ben Ho Park
Publicado 2015Artigo -
9
Ki-67 is required for maintenance of cancer stem cells but not cell proliferation por Justin Cidado, Hong Yuen Wong, David Rosen, Ashley Cimino‐Mathews, Joseph P. Garay, Abigail G. Fessler, Zeshaan A. Rasheed, Jessica Hicks, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Morassa Mohseni, Julia A. Beaver, David Chu, Karen Cravero, Eric S. Christenson, Arielle J. Medford, Austin K. Mattox, Angelo M. De Marzo, Pedram Argani, Ajay Chawla, Paula J. Hurley, Josh Lauring, Ben Ho Park
Publicado 2016Artigo -
10
Mutation of a single allele of the cancer susceptibility gene <i>BRCA1</i> leads to genomic instability in human breast epithelial cells por Hiroyuki Konishi, Morassa Mohseni, Akina Tamaki, Joseph P. Garay, Sarah Croessmann, Sivasundaram Karnan, Akinobu Ota, Hong Yuen Wong, Yuko Konishi, Bedri Karakas, Khola Tahir, Abde M. Abukhdeir, John P. Gustin, Justin Cidado, Grace M. Wang, David Cosgrove, Rory L. Cochran, Danijela Jelovac, Michaela J. Higgins, Sabrina Arena, Lauren Hawkins, Josh Lauring, Amy L. Gross, Christopher M. Heaphy, Yositaka Hosokawa, Edward Gabrielson, Alan K. Meeker, Kala Visvanathan, Pedram Argani, Kurtis E. Bachman, Ben Ho Park
Publicado 2011Artigo -
11
<i>ESR1</i> Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients por David Chu, Costanza Paoletti, Christina L. Gersch, Dustin A. VanDenBerg, Daniel J. Zabransky, Rory L. Cochran, Hong Yuen Wong, Patricia Valda Toro, Justin Cidado, Sarah Croessmann, Bracha Erlanger, Karen Cravero, Kelly Kyker-Snowman, Berry Button, Heather A. Parsons, W. Brian Dalton, Riaz Gillani, Arielle J. Medford, Kimberly Aung, Nahomi Tokudome, Arul M. Chinnaiyan, Anne F. Schott, Dan R. Robinson, Karen S. Jacks, Josh Lauring, Paula J. Hurley, Daniel F. Hayes, James M. Rae, Ben Ho Park
Publicado 2015Artigo -
12
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer por Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Hong Yuen Wong, Patricia Valda Toro, Justin Cidado, Brian Blair, David Chu, Timothy F. Burns, Michaela J. Higgins, Vered Stearns, Lisa K. Jacobs, Mehran Habibi, Julie R. Lange, Paula J. Hurley, Josh Lauring, Dustin A. VanDenBerg, Jill Kessler, Stacie C. Jeter, Michael L. Samuels, Dianna Maar, Leslie Cope, Ashley Cimino‐Mathews, Pedram Argani, Antonio C. Wolff, Ben Ho Park
Publicado 2014Artigo -
13
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia por Adriana E. Tron, Matthew A. Belmonte, Ammar Adam, Brian Aquila, Lawrence Boise, Elisabetta Chiarparin, Justin Cidado, Kevin J. Embrey, Eric T. Gangl, Francis D. Gibbons, Gareth P. Gregory, David Hargreaves, J. Adam Hendricks, Jeffrey W. Johannes, Ricky W. Johnstone, Steven L. Kazmirski, Jason G. Kettle, Michelle L. Lamb, Shannon M. Matulis, Ajay K. Nooka, Martin J. Packer, Bo Peng, Philip B. Rawlins, Daniel Robbins, Alwin G. Schuller, Nancy Su, Wenzhan Yang, Qing Ye, Xiaolan Zheng, J. Paul Secrist, Edwin Clark, David M. Wilson, Stephen E. Fawell, Alexander W. Hird
Publicado 2018Artigo -
14
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations por Azadeh C. Bashi, Elizabeth A. Coker, Krishna C. Bulusu, Patricia Jaaks, Claire Crafter, Howard Lightfoot, Marta Milo, Katrina McCarten, David F. Jenkins, Dieudonne van der Meer, James T. Lynch, Syd Barthorpe, Courtney L. Andersen, Simon T. Barry, Alexandra Beck, Justin Cidado, Jacob Gordon, Caitlin Hall, James Hall, Iman Mali, Tatiana Mironenko, Kevin Mongeon, James Morris, Laura Richardson, Paul D. Smith, Omid Tavana, Charlotte Tolley, Frances Thomas, Brandon S. Willis, Wanjuan Yang, Mark J. O’Connor, Ultan McDermott, Susan E. Critchlow, Lisa Drew, Stephen E. Fawell, Jerome T. Mettetal, Mathew J. Garnett
Publicado 2024Artigo -
15
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia por Srividya B. Balachander, Steven W. Criscione, Kate F. Byth, Justin Cidado, Ammar Adam, Paula Lewis, Terry Macintyre, Shenghua Wen, Deborah Lawson, Kathleen A. Burke, Tristan Lubinski, Jeffrey W. Tyner, Stephen E. Kurtz, Shannon K. McWeeney, Jeffrey Varnes, R. Bruce Diebold, Thomas W. Gero, Stephanos Ioannidis, Edward J. Hennessy, William McCoull, Jamal Saeh, Areya Tabatabai, Omid Tavana, Nancy Su, Alwin G. Schuller, Mathew J. Garnett, Patricia Jaaks, Elizabeth A. Coker, Gareth P. Gregory, Andrea Newbold, Ricky W. Johnstone, Eric T. Gangl, Martin Wild, Michael Zinda, J. Paul Secrist, Barry R. Davies, Stephen E. Fawell, Francis D. Gibbons
Publicado 2020Artigo
Herramientas de búsqueda:
Materias Relacionadas
Biology
Cancer research
Cancer
Genetics
Internal medicine
Medicine
Gene
Breast cancer
Apoptosis
Biochemistry
Biotechnology
Cell biology
In vivo
Mutation
Oncology
Pharmacology
Chronic lymphocytic leukemia
Immunology
Leukemia
Myeloid
Myeloid leukemia
Pathology
Venetoclax
Bioinformatics
Carcinogenesis
Cell
Cell culture
Cell growth
Chemistry
DNA